Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Afatinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Afatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Afuresertib	AKT Inhibitor	Solid Tumour
Molecule Afuresertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Alectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Alectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Almonertinib (Furmonertinib)	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Almonertinib (Furmonertinib) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Anlotinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Anlotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Apatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Apatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
ARV-110 (Bavdegalutamide)	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule ARV-110 (Bavdegalutamide) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-471 (Vepdegestrant)	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule ARV-471 (Vepdegestrant) Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Avapritinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Avapritinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Avutometinib	RAF/MEK Clamp	Solid Tumour
Molecule Avutometinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RAF/MEK Clamp
Axitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Axitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Bavdegalutamide	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule Bavdegalutamide Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)

Afatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Afuresertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Alectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Almonertinib (Furmonertinib) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Anlotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Apatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
ARV-110 (Bavdegalutamide) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
ARV-471 (Vepdegestrant) Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Avapritinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Avutometinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RAF/MEK Clamp
Axitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Bavdegalutamide Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)

‹ 1 2 3 4 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Afatinib

Afuresertib

Alectinib

Almonertinib (Furmonertinib)

Anlotinib

Apatinib

ARV-110 (Bavdegalutamide)

ARV-471 (Vepdegestrant)

Avapritinib

Avutometinib

Axitinib

Bavdegalutamide

Afatinib

Afuresertib

Alectinib

Almonertinib (Furmonertinib)

Anlotinib

Apatinib

ARV-110 (Bavdegalutamide)

ARV-471 (Vepdegestrant)

Avapritinib

Avutometinib

Axitinib

Bavdegalutamide